NCT02807298View on ClinicalTrials.gov

4% Articaine and 2% Lidocaine by Intraligamentary Technique in Irreversible Pulpitis

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

December 31, 2014

Conditions
Irreversible Pulpitis
Interventions
DRUG

4%articaine

intraligamentary injections of 0.9 ml of 4%articaine and 1:100,000 epinephrine

DRUG

2% Lignocaine

Intraligamentary injections of 1.8 ml of lidocaine and 1:100,000 epinephrine

DRUG

Epinephrine

Intraligamentary injections of 1.8 ml of lidocaine and 1:100,000 epinephrine

All Listed Sponsors
lead

Dr. D. Y. Patil Dental College & Hospital

OTHER

NCT02807298 - 4% Articaine and 2% Lidocaine by Intraligamentary Technique in Irreversible Pulpitis | Biotech Hunter | Biotech Hunter